Related Experiment Video
Updated: May 11, 2026

3D-Neuronavigation In Vivo Through a Patient's Brain During a Spontaneous Migraine Headache
Published on: June 2, 2014
Indomethacin-induced de novo headache in hemicrania continua--fighting fire with fire?
Tim P Jürgens1, Laura H Schulte, Arne May
1Department of Systems Neuroscience, University Medical Center Hamburg-Eppendorf, Germany.
Introduction:
The response to indomethacin is an important feature for the diagnosis of hemicrania continua.
Case Description:
We report the case of a 34-year-old female patient with a one-year history of strictly unilateral continuous headache with accompanying ipsilateral autonomic symptoms. As diagnostic testing was unremarkable, hemicrania continua was suspected. A dose of 150 mg of indomethacin/day reduced the headache by 80%. Although an increase to 225 mg/day led to a further reduction of headaches, a new onset of moderate to severe pulsating migrainous bilateral headache developed.
Discussion:
As shown in older studies, indomethacin can induce de novo headaches in a presumably dose-related fashion although the exact mechanism in uncertain. A treatable secondary origin of the indomethacin-induced headaches in patients with hemicrania continua or paroxysmal hemicrania (such as reversible cerebral vasoconstriction syndrome or aseptic meningitis) should be considered and excluded by further diagnostic testing if headaches persist after discontinuation of indomethacin.
Related Concept Videos
Chemotherapy-Induced Nausea and Vomiting: Neurokinin-1 Receptor Antagonists
Chemotherapy-Induced Nausea and Vomiting: Cannabinoids
Two synthetic agonists of THC,...
Acute Inflammation II: Local and Systemic Effects
Chemotherapy-Induced Nausea and Vomiting: Dopamine Receptor Antagonists
Phenothiazines, such as prochlorperazine...
Desensitization and Tachyphylaxis
Several...
Chemotherapy-Induced Nausea and Vomiting: 5-HT3 Receptor Antagonists

